FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199080080> ?p ?o ?g. }

• W3199080080 endingPage "1244" @default.
• W3199080080 startingPage "1244" @default.
• W3199080080 abstract "Up to now, the chemotherapy approaches for glioblastoma were limited. 1-[2-Thiazolylazo]-2-naphthol (named as NSC139021) was shown to significantly inhibit the proliferation of prostate cancer cells by targeting the atypical protein kinase RIOK2. It is documented that RIOK2 overexpressed in glioblastoma. However, whether NSC139021 can inhibit the growth of glioblastoma cells and be a potential drug for glioblastoma treatment need to be clarified. In this study, we investigated the effects of NSC139021 on human U118MG, LN-18, and mouse GL261 glioblastoma cells and the mouse models of glioblastoma. We verified that NSC139021 effectively inhibited glioblastoma cells proliferation, but it is independent of RIOK2. Our data showed that NSC139021 induced cell cycle arrest at G0/G1 phase via the Skp2-p27/p21-Cyclin E/CDK2-pRb signaling pathway in G1/S checkpoint regulation. In addition, NSC139021 also increased the apoptosis of glioblastoma cells by activating the p53 signaling pathway and increasing the levels of Bax and cleaved caspase 3. Furthermore, intraperitoneal administration of 150 mg/kg NSC139021 significantly suppressed the growth of human and mouse glioblastoma in vivo. Our study suggests that NSC139021 may be a potential chemotherapy drug for the treatment of glioblastoma by targeting the Skp2-p27/p21-Cyclin E/CDK2-pRb signaling pathway." @default.
• W3199080080 created "2021-09-27" @default.
• W3199080080 creator A5018863416 @default.
• W3199080080 creator A5021459428 @default.
• W3199080080 creator A5026922421 @default.
• W3199080080 creator A5066053678 @default.
• W3199080080 creator A5077741855 @default.
• W3199080080 creator A5087766294 @default.
• W3199080080 date "2021-09-17" @default.
• W3199080080 modified "2023-10-14" @default.
• W3199080080 title "RIOK2 Inhibitor NSC139021 Exerts Anti-Tumor Effects on Glioblastoma via Inducing Skp2-Mediated Cell Cycle Arrest and Apoptosis" @default.
• W3199080080 cites W1971034699 @default.
• W3199080080 cites W1992913416 @default.
• W3199080080 cites W1996588976 @default.
• W3199080080 cites W2019408755 @default.
• W3199080080 cites W2020235979 @default.
• W3199080080 cites W2051257252 @default.
• W3199080080 cites W2063864717 @default.
• W3199080080 cites W2073996456 @default.
• W3199080080 cites W2075296132 @default.
• W3199080080 cites W2078510083 @default.
• W3199080080 cites W2096287682 @default.
• W3199080080 cites W2098817749 @default.
• W3199080080 cites W2115276344 @default.
• W3199080080 cites W2115862526 @default.
• W3199080080 cites W2160356867 @default.
• W3199080080 cites W2383224891 @default.
• W3199080080 cites W2595618349 @default.
• W3199080080 cites W2774907925 @default.
• W3199080080 cites W2800469107 @default.
• W3199080080 cites W2801926766 @default.
• W3199080080 cites W2872710185 @default.
• W3199080080 cites W2884741638 @default.
• W3199080080 cites W2894953910 @default.
• W3199080080 cites W3003982277 @default.
• W3199080080 cites W3009745811 @default.
• W3199080080 cites W3011214003 @default.
• W3199080080 cites W3113919386 @default.
• W3199080080 cites W4212949515 @default.
• W3199080080 doi "https://doi.org/10.3390/biomedicines9091244" @default.
• W3199080080 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8470931" @default.
• W3199080080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34572430" @default.
• W3199080080 hasPublicationYear "2021" @default.
• W3199080080 type Work @default.
• W3199080080 sameAs 3199080080 @default.
• W3199080080 citedByCount "5" @default.
• W3199080080 countsByYear W31990800802022 @default.
• W3199080080 countsByYear W31990800802023 @default.
• W3199080080 crossrefType "journal-article" @default.
• W3199080080 hasAuthorship W3199080080A5018863416 @default.
• W3199080080 hasAuthorship W3199080080A5021459428 @default.
• W3199080080 hasAuthorship W3199080080A5026922421 @default.
• W3199080080 hasAuthorship W3199080080A5066053678 @default.
• W3199080080 hasAuthorship W3199080080A5077741855 @default.
• W3199080080 hasAuthorship W3199080080A5087766294 @default.
• W3199080080 hasBestOaLocation W31990800801 @default.
• W3199080080 hasConcept C104317684 @default.
• W3199080080 hasConcept C105696609 @default.
• W3199080080 hasConcept C120504264 @default.
• W3199080080 hasConcept C128473837 @default.
• W3199080080 hasConcept C134459356 @default.
• W3199080080 hasConcept C184235292 @default.
• W3199080080 hasConcept C185592680 @default.
• W3199080080 hasConcept C190283241 @default.
• W3199080080 hasConcept C25602115 @default.
• W3199080080 hasConcept C2776787872 @default.
• W3199080080 hasConcept C2778227246 @default.
• W3199080080 hasConcept C2778437423 @default.
• W3199080080 hasConcept C29537977 @default.
• W3199080080 hasConcept C502942594 @default.
• W3199080080 hasConcept C55493867 @default.
• W3199080080 hasConcept C62112901 @default.
• W3199080080 hasConcept C62478195 @default.
• W3199080080 hasConcept C82495950 @default.
• W3199080080 hasConcept C86803240 @default.
• W3199080080 hasConcept C95444343 @default.
• W3199080080 hasConceptScore W3199080080C104317684 @default.
• W3199080080 hasConceptScore W3199080080C105696609 @default.
• W3199080080 hasConceptScore W3199080080C120504264 @default.
• W3199080080 hasConceptScore W3199080080C128473837 @default.
• W3199080080 hasConceptScore W3199080080C134459356 @default.
• W3199080080 hasConceptScore W3199080080C184235292 @default.
• W3199080080 hasConceptScore W3199080080C185592680 @default.
• W3199080080 hasConceptScore W3199080080C190283241 @default.
• W3199080080 hasConceptScore W3199080080C25602115 @default.
• W3199080080 hasConceptScore W3199080080C2776787872 @default.
• W3199080080 hasConceptScore W3199080080C2778227246 @default.
• W3199080080 hasConceptScore W3199080080C2778437423 @default.
• W3199080080 hasConceptScore W3199080080C29537977 @default.
• W3199080080 hasConceptScore W3199080080C502942594 @default.
• W3199080080 hasConceptScore W3199080080C55493867 @default.
• W3199080080 hasConceptScore W3199080080C62112901 @default.
• W3199080080 hasConceptScore W3199080080C62478195 @default.
• W3199080080 hasConceptScore W3199080080C82495950 @default.
• W3199080080 hasConceptScore W3199080080C86803240 @default.
• W3199080080 hasConceptScore W3199080080C95444343 @default.
• W3199080080 hasFunder F4320321001 @default.
• W3199080080 hasIssue "9" @default.

• next